Australia, 21st May 2025, – Neuralia TMS, a leading provider of neuromodulation therapies, has strengthened its presence in Melbourne with the delivery of advanced Transcranial Magnetic Stimulation (TMS) therapy services. This development highlights the clinic’s commitment to providing non-invasive, drug-free treatment options for a range of neurological and mental health conditions.

Neuralia TMS offers a variety of innovative therapies, including TMS, transcranial Direct Current Stimulation (tDCS), and pharmacogenetic testing designed to tailor treatments to individual genetic profiles. These services target conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), chronic pain, and Parkinson’s disease.

Dr Shanek Wick, medical director at Neuralia TMS, commented on the significance of these offerings: “Advanced TMS therapy represents a promising alternative for individuals seeking treatment beyond conventional medication. The non-invasive nature and personalised approach of these therapies provide patients with options that address their specific health needs while minimising side effects.”

Operating from Moonee Ponds, Victoria, Neuralia TMS combines clinical expertise with cutting-edge technology to deliver tailored treatment plans. The inclusion of pharmacogenetic testing enables the optimisation of therapy effectiveness by considering genetic factors influencing medication response.

Looking ahead, Dr Wick highlighted the clinic’s focus on innovation and patient-centred care: “As neuromodulation technologies evolve, continued integration of scientific advances will be crucial. Neuralia TMS aims to enhance treatment accessibility and effectiveness by expanding therapy options and refining personalised care approaches.”

Neurological and mental health conditions treated by Neuralia TMS often require comprehensive management strategies. Therapies such as TMS and tDCS offer alternatives for patients who may have experienced limited success with traditional treatments or prefer drug-free options.

The clinic’s approach is grounded in evidence-based practice, utilising validated protocols and ongoing research to inform treatment delivery. The ability to adapt treatments based on pharmacogenetic insights represents a step forward in personalised medicine, aiming to improve patient outcomes.

Neuralia TMS provides a supportive environment for patients, combining medical oversight with the latest neuromodulation techniques. This comprehensive model seeks to address complex conditions through tailored, patient-specific interventions.

Dr Wick noted the importance of evolving alongside emerging scientific knowledge: “Remaining at the forefront of neuromodulation therapy involves continuous learning and adaptation. The goal is to maintain high standards of care while incorporating new methodologies that benefit patients’ health and quality of life.”

For further information about Neuralia TMS and its advanced TMS Melbourne therapy services, the clinic can be contacted by phone at 08 9122 5246 or via email at info@corticaltms.com.au. The clinic is located at 102/149-155 Pascoe Vale Rd, Moonee Ponds, Victoria, 3039.

Media Contact

Organization: Neuralia TMS

Contact
Person: Dr Shanek Wick

Website:

https://www.neuraliatms.com.au/

Email:

info@neuralia.com.au

Contact Number: 61891225246

Address:102/149-155 Pascoe Vale Rd

Address 2: Moonee Ponds, Victoria, 3039

Country:Australia

The post Neuralia TMS Delivers Advanced TMS Therapy Services in Melbourne appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.